# Calithera Biosciences, Inc. (CALA)

> Healthcare · US · Reports in USD

Fundamental indicators from Sponda, adjusted for inflation.

[HTML version](https://sponda.capital/en/CALA/fundamentals)

## Annual figures

| Year | Revenue (M) | Net Inc. (M) | FCF (M) | Debt (M) | Equity (M) |
| --- | --- | --- | --- | --- | --- |
| 2022 | $ 0 | $ -22.75M | $ -48.86M | $ 1.67M | $ 20.39M |
| 2021 | $ 11.59M | $ -197.20M | $ -78.98M | $ 3.04M | $ -491.33M |
| 2020 | $ 0 | $ -114.83M | $ -107.49M | $ 6.72M | $ 102.37M |
| 2019 | $ 0 | $ -115.99M | $ -101.65M | $ 8.20M | $ 142.43M |
| 2018 | $ 29.39M | $ -72.15M | $ -85.92M | $ 0 | $ 126.71M |
| 2017 | $ 34.96M | $ -37.49M | $ 16.87M | $ 0 | $ 150.31M |
| 2016 | $ 0 | $ -52.29M | $ -43.24M | $ 0 | $ 49.91M |
| 2015 | $ 0 | $ -45.83M | $ -42.65M | $ 0 | $ 71.79M |
| 2014 | $ 0 | $ -30.68M | $ -27.96M | $ 0 | $ 100.37M |
| 2013 | $ 0 | $ -10.53M | $ -10.26M | $ 0 | $ -20.81M |

Columns not available in this view: annualPriceMultiples, dividends. They require live market data and are shown on the HTML page instead.

## Leverage and liquidity

| Indicator | Value |
| --- | --- |
| Gross Debt / Eq | 0.08 |
| Liabilities / Eq | 0.41 |
| Current Ratio | 3.60 |

## Other views

- [Metrics](https://sponda.capital/en/CALA.md)
- [Charts](https://sponda.capital/en/CALA/charts.md)
- [Compare](https://sponda.capital/en/CALA/compare.md)
- [Indicator definitions](https://sponda.capital/en/screener.md)

Data as of 2026-08-27.